Common Shares Outstanding: The number of class A shares currently held by investors.
Dyne Therapeutics, Inc. (DYN) had Common Shares Outstanding of 187.33M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-193.55M |
|
-- |
|
-- |
|
$197.07M |
|
$-197.07M |
|
$3.52M |
|
$-193.55M |
|
$-193.55M |
|
$-193.55M |
|
$-193.55M |
|
$-193.55M |
|
$-193.55M |
|
$-197.07M |
|
$-196.66M |
|
181.77M |
|
181.77M |
|
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$1.18B |
|
$7.14M |
|
$58.77M |
|
$1.23B |
|
$90.55M |
|
$200.01M |
|
$213.32M |
|
$303.87M |
|
$930.93M |
|
$930.93M |
|
$930.93M |
|
|
Common Shares Outstanding |
187.33M |
| Cash Flow Statement Financials | |
$-452.70M |
|
$-8.48M |
|
$483.28M |
|
$895.74M |
|
$917.84M |
|
$22.10M |
|
$44.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.99 |
|
-- |
|
-- |
|
0.18 |
|
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-456.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.79% |
|
-20.79% |
|
-15.67% |
|
-17.11% |
|
$4.97 |
|
$-2.51 |
|
$-2.49 |
|